Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

48.03 +0.49 (+1.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 15, 2013
Form 4
Source: SEC/Edgar
May 15, 2013
Form 3
Source: SEC/Edgar
March 27, 2013
Form 4
Source: SEC/Edgar
March 27, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 05, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
February 04, 2013
Form 4
Source: SEC/Edgar
November 28, 2012
Form 4
Source: SEC/Edgar
November 13, 2012
Form 4
Source: SEC/Edgar
November 13, 2012
Form 4
Source: SEC/Edgar
August 27, 2012
Form 4
Source: SEC/Edgar
August 13, 2012
Form 4
Source: SEC/Edgar
June 04, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 16, 2012
Form 4
Source: SEC/Edgar
May 15, 2012
Form 4
Source: SEC/Edgar
May 06, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Form 4
Source: SEC/Edgar
May 03, 2012
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.